Positron Emission Tomography

临床试验

计划入组 60 人 · 首次发布于 2019 年 6 月 28 日

招募中

NCT06453915

NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease

计划入组 12 人 · 首次发布于 2024 年 6 月 12 日

已完成

NCT01721473

Brain Nicotine Receptor Density in Veteran Smokers

计划入组 184 人 · 首次发布于 2012 年 11 月 4 日

药物

查看全部 43 →

Small Molecule

Approved

Ammonia N-13(Ammonia N 13)

相关疾病：Coronary Artery Disease (CAD)

H₃N

Small Molecule

Approved

Fludeoxyglucose (18F)

相关疾病：Cancer, Coronary Artery Disease (CAD)，另有 2 项

C₆H₁₁FO₅

Small Molecule

Approved

Copper oxodotreotide Cu-64

相关疾病：Somatostatin Receptor Positive Neuroendocrine Tumours

C₆₅H₈₈CuN₁₄O₁₉S₂

机构

查看全部 19 →

RadNet

United States

Telix Pharmaceuticals

Australia

POSITRON TRACERS PTE. LTD.

Singapore

资讯

查看全部 537 →

去年

Persistent Tumor Hypoxia Predicts Distant Metastasis in Head and Neck Cancer

去年

Positron Corporation Secures $8 Million Investment to Expand PET-CT Imaging Technology

3个月前

临床试验

18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma

NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease

Brain Nicotine Receptor Density in Veteran Smokers

药物

Ammonia N-13(Ammonia N 13)

Fludeoxyglucose (18F)

Copper oxodotreotide Cu-64

机构

RadNet

Telix Pharmaceuticals

POSITRON TRACERS PTE. LTD.

资讯

Persistent Tumor Hypoxia Predicts Distant Metastasis in Head and Neck Cancer

Positron Corporation Secures $8 Million Investment to Expand PET-CT Imaging Technology

Ionetix Receives First ANDA Approval for Gallium Ga-68 Gozetotide PSMA-PET Imaging Agent